Ezetimibe for the Treatment of Nonalcoholic Steatohepatitis: Assessment by Novel Magnetic Resonance Imaging and Magnetic Resonance Elastography in a Randomized Trial (MOZART Trial)

Ezetimibe inhibits intestinal cholesterol absorption and lowers low-density lipoprotein cholesterol. Uncontrolled studies have suggested that it reduces liver fat as estimated by ultrasound in nonalcoholic steatohepatitis (NASH). Therefore, we aimed to examine the efficacy of ezetimibe versus placeb...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Hepatology
Hauptverfasser: Loomba, Rohit, Sirlin, Claude B, Ang, Brandon, Bettencourt, Ricki, Jain, Rashmi, Salotti, Joanie, Soaft, Linda, Hooker, Jonathan, Kono, Yuko, Bhatt, Archana, Hernandez, Laura, Nguyen, Phirum, Noureddin, Mazen, Haufe, William, Hooker, Catherine, Yin, Meng, Ehman, Richard, Lin, Grace Y, Valasek, Mark A, Brenner, David A, Richards, Lisa
Format: Artigo
Sprache:Inglês
Veröffentlicht: BlackWell Publishing Ltd 2015
Schlagworte:
Steatohepatitis/Metabolic Liver Disease
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4407930/
https://ncbi.nlm.nih.gov/pubmed/25482832
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.27647
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge